✦ LIBER ✦

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

✍ Scribed by Remberger, M; Svahn, B-M; Hentschke, P; Löfgren, C; Ringdén, O

Book ID: 110012228
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 69 KB
Volume: 24
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701991

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of human leucocyte antigen mismat

Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors

✍ Takanori Teshima; Keitaro Matsuo; Kosei Matsue; Fumio Kawano; Shuichi Taniguchi; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Outcome of haematopoietic stem cell tran

Outcome of haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia in third complete remission: a vital role for graft-versus-host-disease/ graft-versus-leukaemia effect in survival

✍ Adam Gassas; M Kashif Ishaqi; Samina Afzal; Annie Dupuis; John Doyle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Low incidence of severe acute graft-vers

Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing

✍ Giebel, S; Giorgiani, G; Martinetti, M; Zecca, M; Maccario, R; Salvaneschi, L; H 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

The effect of the serotherapy regimen us

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia

✍ Byrne, J L; Stainer, C; Cull, G; Haynes, A P; Bessell, E M; Hale, G; Waldmann, H 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 81 KB

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets